Health Canada evaluating NDMA in metformin drugs
In plain language
Health Canada is evaluating metformin drugs for an impurity called NDMA. Some metformin products outside Canada have been found to contain NDMA above acceptable limits. Metformin is a prescription drug used to control high blood sugar in patients with type 2 diabetes. Health Canada is not aware of any metformin products in Canada containing NDMA above acceptable levels at this time.
What to do
- Do not stop taking your metformin drug without first discussing options with your health care provider.
- Consult your healthcare provider if you have concerns.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Specific affected products are listed in the official notice.
Do I have this product?
This recall applies to specific products. Details are listed in the official notice.
Frequently Asked Questions
Why was this product recalled?
Health Canada is evaluating metformin drugs for an impurity called NDMA. Some metformin products outside Canada have been found to contain NDMA above acceptable limits. Metformin is a prescription drug used to control high blood sugar in patients with type 2 diabetes. Health Canada is not aware of any metformin products in Canada containing NDMA above acceptable levels at this time.
What should consumers do?
Do not stop taking your metformin drug without first discussing options with your health care provider. Consult your healthcare provider if you have concerns.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
A potential safety risk has been identified with this product. Stop using it immediately and follow the instructions in the official recall notice.
When was this product recalled?
This product was recalled on December 5, 2019.